Sevoflurane, but not propofol, reduces the lung inflammatory response and improves oxygenation in an acute respiratory distress syndrome model: A randomised laboratory study

European Journal of Anaesthesiology

Volumn 30, Issue 8, 2013, Pages 455-463

  Ferrando, Carlos ^a   Aguilar, Gerardo ^a   Piqueras, Laura ^a   Soro, Marina ^a   Moreno, Joaquin ^a   Belda, Francisco J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROPOFOL; SEVOFLURANE; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ANESTHETIC EQUIPMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED STUDY; HEMODYNAMICS; LUNG LAVAGE; NEUTROPHIL COUNT; NONHUMAN; OXYGENATION; PNEUMONIA; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SWINE; TIDAL VOLUME; TRACHEOBRONCHIAL TOILET;

ANESTHESIA; ANESTHETICS, INHALATION; ANIMALS; CELL MEMBRANE PERMEABILITY; DISEASE MODELS, ANIMAL; HEMODYNAMICS; INFLAMMATION; INFUSIONS, INTRAVENOUS; LUNG; MACROPHAGES; METHYL ETHERS; MONITORING, INTRAOPERATIVE; NEUTROPHILS; OXYGEN; PROPOFOL; RANDOM ALLOCATION; RESPIRATORY DISTRESS SYNDROME, ADULT; SWINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884469046     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32835f0aa5     Document Type: Article

References (54)

1. Spragg RG, Bernard GR, Checkley W, et al. Beyond mortality. Future clinical research in acute lung injury. Am J Respir Crit Care Med 2010; 181:1121-1127.
2. Gu? nther A, Walmrath D, Grimminger F, Seeger W. Pathophysiology of acute lung injury. Semin Respir Crit Care Med 2001; 22:247-258. (Pubitemid 32729495)
3. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301-1308.
4. Ranieri V, Suter P, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomised controlled trial. JAMA 1999; 282:54-61. (Pubitemid 29318933)
5. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protectiveventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1999; 338:347-354.
6. Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anaesthesiol 2005; 19:523-538. (Pubitemid 40753816)
7. Belda JF, Soro M, Badenes R, et al. The predictive performance of a pharmacokinetic model for manually adjusted infusion of liquid sevoflurane for use with the anesthetic-conserving device (AnaConDa): a clinical study. Anesth Analg 2008; 106:1207-1213.
8. Soro M, Belda FJ, Badenes R, Alcantara MJ. Use of the AnaConDa (anesthesia conserving device) with sevoflurane in critical care patients. Eur J Anaesthesiol 2004; 21 (Suppl 32):A-708.
9. Giraud O, Molliex S, Rolland C, et al. Halogenated anesthetics reduce interleukin-1beta-induced cytokine secretion by rat alveolar type II cells in primary culture. Anesthesiology 2003; 98:74-81. (Pubitemid 36043412)
10. Mitsuhata H, Shimizu R, Yokoyama M. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol 1995; 17:529-534.
11. Boost K, Hofstetter C, Flondor M, et al. Desflurane differentially affects the release of proinflammatory cytokines in plasma and bronchoalveolar fluid of endotoxemic rats. Int J Molec Med 2006; 17:1139-1144.
12. Suter D, Spahn DR, Blumenthal S, et al. The inmunommodulatory effect of sevoflurane in endotoxin-injured alveolar epithelial cells. Anesth Analg 2007; 104:638-645.
13. Yue T, Roth Z?graggen B, Blumenthal S, et al. Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro. Eur Respir J 2008; 31:118-125.
14. Kotani N, Hashimoto H, Sessler DI, et al. Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia. Anesth Analg 1999; 89:1250-1256. (Pubitemid 29521949)
15. Helmy SA, Al-Attiyah RJ. The immunomodulatory effects of prolonged intravenous infusion of propofol versus midazolam in critically ill surgical patients. Anaesthesia 2001; 56:4-8. (Pubitemid 32111865)
16. Chu CH, David Liu D, Hsu YH, et al. Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats. Pulm Pharmacol Ther 2007; 20:503-512. (Pubitemid 47077639)
17. Chen H, Hsieh N, Kao S. Protective effects of propofol on acute lung injury induced by oleic acid in conscious rats. Crit Care Med 2008; 36:1214-1221. (Pubitemid 351482671)
18. Voigtsberger S, Lachmann RA, Leutert AC, et al. Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide- induced lung injury. Anesthesiology 2009; 111:1238-1248.
19. Schilling T, Kozian A, Senturk M, et al. Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients. Anesthesiology 2011; 115:65-74.
20. Kalb R, Schober P, Schwarte LA, et al. Preconditioning, but not postconditioning, with sevoflurane reduces pulmonary neutrophil accumulation after lower ischaemia/reperfusion injury in rats. Eur J Anaesthiol 2008; 25:454-459. (Pubitemid 351629962)
21. Takala RS, Soukka HR, Salo MS, et al. Pulmonary inflammatory mediators after sevoflurane and thiopentone anaesthesia in pigs. Acta Anaesthesiol Scand 2004; 48:40-45. (Pubitemid 38063117)
22. Takala R, Soukka H, Kirvela O. Alveolar integrity and ultrastructure in pigs remain undamaged after exposure to sevoflurane. Acta Anaesthesiol Scand 2002; 46:1137-1143.
23. Haitsma J, Lachmann B, Papadakos P, et al. Additives in intravenous anesthesia modulates pulmonary inflammation in a model of LPS-induced respiratory distress. Acta Anaesthesiol Scand 2009; 53:176-182.
24. Herr D, Kelly K, Hall J, et al. Safety and efficacy of propofol with EDTA when used for sedation of surgical intensive care unit patients. Intensive Care Med 2005; 26:S452-S462.
25. Bernard G, Artigas A, Brigham K, et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149:818-827.
26. Spragg R, Lewis J, Wurst W, et al. Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med 2003; 167:1562-1566. (Pubitemid 37363368)
27. Anzueto A, Baughman R, Guntupalli K, et al., Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. Aerosolized surfactant in adults with sepsis-induced respiratory distress syndrome. N Engl J Med 1996; 334:1417-1421. (Pubitemid 26157436)
28. Matute-Bello G, Frevert G, Martin T. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 295:L379-L399.
29. Karmrodt J, Bletz C, Yuan S, et al.Quantification of atelectatic lung volumes in two different porcine models of ARDS. Br J Anaesth 2006; 97:883-895. (Pubitemid 44823680)
30. Gruenewald M, Renner J, Meybohm P, et al. Reliability of continuous cardiac output measurement during intra-abdominal hypertension relies on repeated calibrations: an experimental animal study. Crit Care 2008; 12:R132.
31. da Silva Ramos FJ, de Oliveira EM, Park M, et al. Heart-lung interactions with different ventilatory settings during acute lung injury and hypovolaemia: an experimental study. Br J Anaesth 2011; 106:394-402.
32. Campbell G. Blinded invasive diagnosis procedures in ventilatorassociated pneumonia. Chest 2000; 120:207S-211S. (Pubitemid 30230861)
33. Perkins G, Chaterjee S, Giles S, et al. Safety and tolerability of nonbronchoscopic lavage in ARDS. Chest 2005; 127:1358-1363. (Pubitemid 46224301)
34. Naik AS, Kallapur SG, Bachurski CJ, et al. Effects of ventilation with different positive end-expiratory pressures on cytokine expression in the preterm lamb lung. Am J Respir Crit Care Med 2001; 164:494-498. (Pubitemid 32778222)
35. Frank JA, Parsons PE, Matthay MA. Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest 2006; 130:1906-1914. (Pubitemid 46033452)
36. Lee HT, Ota-Setlik A, Fu Y, et al. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 2004; 101:1313-1324. (Pubitemid 39564987)
37. Giraud O, Seince PF, Rolland C, et al. Halothane reduces the early lipopolysaccharide-induced lung inflammation in mechanically ventilated rats. Am J Respir Crit Care Med 2000; 162:2278-2286. (Pubitemid 32051701)
38. Kotani N, Takahashi S, Sessler DI, et al. Volatile anesthetics augment expression of proinflammatory cytokines in rat alveolar macrophages during mechanical ventilation. Anesthesiology 1999; 91:187-197. (Pubitemid 29307352)
39. Hu G, Schwartz DE, Shajahan AN, et al. Isoflurane, but not sevoflurane, increases transendothelial albumin permeability in the isolated rat lung. Anesthesiology 2006; 104:777-785.
40. Ware L, Matthay M. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349. (Pubitemid 30408719)
41. Slutsky AS, Tremblay LN. Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 1998; 157:1721-1725.
42. Ranieri VM, Giunta F, Suter PM, Slutsky AS. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA 2000; 284:43-44. (Pubitemid 30445657)
43. Tutor JD, Mason CM, Dobard E, et al. Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med 1994; 149:1107-1111. (Pubitemid 24147046)
44. Stu? ber F, Wrigge H, Schroeder S, et al. Kinetic and reversibility of mechanical ventilation associated pulmonary and systemic inflammatory response in patients with acute lung injury. Intensive Care Med 2002; 28:834-841. (Pubitemid 34762216)
45. Karzai W, Haberstroh J, Priebe HJ. The effects of increasing concentrations of desflurane on systemic oxygenation during one-lung ventilation in pigs. Anesth Analg 1999; 89:215-217. (Pubitemid 29293337)
46. Schwarzkopf K, Schreiber T, Preussler NP, et al. Lung perfusion, shunt fraction, and oxygenation during one-lung ventilation in pigs: the effects of desflurane, isoflurane, and propofol. J Cardiothorac Vasc Anesth 2003; 17:73-75. (Pubitemid 36286452)
47. Pruszkowski O, Dalibon N, Moutafis M, et al. Effects of propofol vs sevoflurane on arterial oxygenation during one-lung ventilation. Br J Anaesth 2007; 98:539-544. (Pubitemid 47072657)
48. Bindels AJ, van der Hoeven JG, Meinders AE. Extravascular lung water in patients with septic shock during a fluid regimen guided by cardiac index. Neth J Med 2000; 57:82-93.
49. Matejovic M, Krouzecky A, Rokyta R Jr, Novak I. Fluid challenge in patients at risk for fluid loading-induced pulmonary edema. Acta Anaesthesiol Scand 2004; 48:69-73. (Pubitemid 38058144)
50. Broccard AF, Hotchkiss JR, Vannay C, et al. Protective effects of hypercapnic acidosis on ventilator-induced lung injury. Am J Respir Crit Care Med 2001; 164:802-806. (Pubitemid 32881917)
51. Lang J, Figueroa M, Sanders K, et al. Hypercapnia via reduced rate and tidal volume contributes to lipopolysaccharide-induced lung injury. Am J Respir Crit Care Med 2005; 171:147-157. (Pubitemid 40105414)
52. Annecke T, Kubitz JC, Kahr S, et al. Effects of sevoflurane and propofol on ischaemia-reperfusió n injury after thoracic-aortic occlusion in pigs. Br J Anaesth 2007; 98:581-590. (Pubitemid 47072610)
53. Greene S. Veterinary anesthesia and pain management secrets. In: Benso T, editor. Lumb & Jones? Veterinary Anesthesia. Baltimore: Williams & Wilkins; 1996. pp. 862-868.
54. Akao Y, Mikawa K, Nishina K, Obara H. Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg 2005; 100:810-816. (Pubitemid 40300081)